Satumomab

N/A

Report date: 2025/09/04 17:53:59

Base Information

Drug NameSatumomab
Drug Alias NameIndium 111In-satumomab pendetidesatumomab pendetideOncoScint CR/OVOncoScint OV103OncoScint OV +[8] 
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody murineBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody diagnosticsRadiation-emitting products > Nuclides > Indium > 111In +[4] 
Mechanisms of ActionRadionuclide imaging enhancers
TargetsTumor-associated glycoprotein 72
Therapy Area/IndicationsOvarian NeoplasmsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesEusa Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEusa Pharma
Active IndicationsN/A
Inactive IndicationsOvarian NeoplasmsColorectal Neoplasms

Other Information

ATC CodeV09IB02
Related LinksWikipediaDrugBankKEGG